The Bonnie J. Addario Lung Cancer Foundation
The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

Bonnie Addario in UCSF Lab
 

Sunesis Pharmaceuticals Reports Positive Initial Results From Phase 2 Small Cell Lung Cancer Trial With SNS-595

lung cancer.jpgPharmaceuticals, Inc.  today announced that the company will advance the small-cell lung cancer trial in treatment-sensitive patients to Stage 2.

This entry was posted on Tuesday, January 30th, 2007 at 11:44 am and is filed under Research, Small-Cell. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

« NCCN Updates Non-Small Cell Lung Cancer Guidelines
Biomoda, Inc., Maker of Early Lung Cancer Detection Test, Joins BIOCOM »

Leave a Reply